PQE Group Announces Release of 2024 Sustainability Report
Company’s second consecutive Report encompasses its full global operations
PQE Group is pleased to announce it has completed and released its 2024 Sustainability Report, which represents a significant milestone for the company as it marks its second report and the first to cover its full global operations. Unlike the previous 2023 edition, which focused solely on its Italian branch, this report provides a comprehensive view of the company’s sustainability strategy and impact across all 23 countries where it operates. Its publication was driven by the European Union’s Corporate Sustainability Reporting Directive (CSRD), a regulation that requires large companies to disclose detailed information on environmental, social, and governance (ESG) issues in a standardized, transparent, and comparable format.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625475562/en/
2024 Pharma Quality Europe Sustainability Report
This obligation reflects the EU’s broader commitment to aligning economic activity with climate and social goals, and is enforced via national legislation based on directives approved by the European Commission, Parliament, and Council. The technical standards behind the reporting, known as the European Sustainability Reporting Standards (ESRS), were developed by the European Financial Reporting Advisory Group (EFRAG) and are designed to help companies assess and communicate both their impacts on the world and the risks sustainability challenges pose to their business.
PQE's report opens with a materiality assessment conducted under the ESRS and Global Reporting Initiative (GRI) frameworks. This process involved stakeholder engagement and identified the most important ESG topics for the company.
In environmental matters, PQE Group transparently disclosed comprehensive greenhouse gas (GHG) emissions aligned with ISO 14064-1:2019 standard, detailing Scope 1, direct emissions; Scope 2 indirect emissions from electricity; and Scope 3 indirect emissions, predominantly from business travel. These detailed emissions disclosures demonstrate PQE Group’s clear pathway toward a lower carbon footprint.
From a social perspective, the company delivered widespread training on inclusive language, DE&I topics, and professional development, while also ensuring safe working environments and fair opportunities for career advancement. Performance evaluations and employee feedback processes were systematized and expanded, and over 2200 internal interviews were performed in 2024.
On the governance side, PQE Group strengthened its commitment to ethical business practices through training, due diligence on partners, and the launch of new initiatives such as the Legality Rating application.
Regulation has become a critical pillar of stakeholder trust. By reporting in full alignment with the CSRD and ESRS, PQE Group reaffirms its dedication to doing business in a way that is not only legal, but deeply principled and transparent.
“While the European Union has issued the requirement to publish documentation showing compliance with EU Legislation and guidelines provided by EFRAG beginning with 2025, I am pleased that PQE Group voluntarily began to develop this Sustainability Report early, launching its 2023 report reflecting its accomplishments pertaining to sustainability in Italy and now, for 2024, its global Sustainability Report,” said Gilda D’Incerti, CEO & Founder of PQE Group. “It’s a large undertaking, identifying a significant amount of information about our company, it’s people, certifications, governance, sustainability initiatives, and more; the results presented in this comprehensive document demonstrate the very important work that PQE has done, and continues to develop, on behalf of maintaining an ongoing focus on sustainability, strong ethics, and company-wide equity based on merit, for Europe and beyond.”
About PQE Group
PQE Group is a woman-owned leading Life Science consulting firm, providing high-quality solutions in GCP, GLP, GMP, and GDP areas to both industry giants and SMEs worldwide. With a focus on innovation, efficiency, and sustainability and with a global presence through its 23 subsidiaries and 40+ offices located around the world, PQE Group continues to set industry benchmarks and drive positive change in the Life Science sector. The Group's CEO & Founder, Gilda D'Incerti, has recently launched ReSQ-UP, a groundbreaking initiative in the Clinical Research Organizations field, focusing on supporting emerging startups in women's health (FemTech), medical devices, and innovations in the medical cannabis sector.
Visit us at PQE Group: Home - PQE Group, and follow PQE Group on LinkedIn, Instagram and Facebook.
The full 2024 Sustainability Report is available for download: https://www2.pqegroup.com/wp-content/uploads/2025/06/Sustainability-Report-PQE-Group-2024_EN_FINAL_compressed.pdf
View source version on businesswire.com: https://www.businesswire.com/news/home/20250625475562/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IFF’s 2024 Do More Good Report Highlights Progress in Sustainability and Innovation25.6.2025 17:00:00 CEST | Press release
The company continues to deliver sustainable solutions that helped customers and consumers avoid 27.3 million metric tons of CO₂e emissions in 2024. IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health, and biosciences—has released its 2024 Do More Good Report which showcases a year of meaningful progress, transformative innovation, and commitment to people and the planet. The report highlights key accomplishments across the organization and emphasizes the impact of IFF’s sustainable solutions through four core pillars, aligned with its new theme, 'The Science of Possible': Conscious Sourcing, Intentional Innovation, Partnerships of Impact, and Operating for the Future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625701433/en/ “We’re working to bring the best of science, creativity and heart to everything we do,” said Erik Fyrwald, IFF CEO. “This report is more than a record of progress — it
Moody’s fully acquires ICR Chile, solidifying its leading position in key Latin American markets25.6.2025 15:00:00 CEST | Press release
Moody’s Corporation (NYSE:MCO) announced today that it has fully acquired ICR Chile (ICR), a leading provider of domestic credit ratings in Chile. The transaction follows Moody’s 2019 acquisition of a minority stake in ICR and will further strengthen its presence in Latin America’s domestic credit markets. Following the transaction, ICR will continue issuing domestic ratings in Chile under its own rating process and methodologies. In the following months, ICR will be fully integrated into Moody’s Local, a group of leading credit rating agencies in Latin America. “Today’s acquisition builds on our successful partnership with ICR and underscores our commitment to Chile’s growing debt capital market,” said Martin Fernandez-Romero, Managing Director of Moody’s Local. “Bringing ICR into Moody’s Local will enhance our ability to provide high quality credit ratings, research, and analytical services to market participants, while contributing to greater transparency in Latin America.” Founded
Empatica Unveils EmbraceMini: The World’s Smallest Actigraphy Wearable for Clinical Trials25.6.2025 15:00:00 CEST | Press release
Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled EmbraceMini, its revolutionary new wearable for clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617320584/en/ EmbraceMini is an ultra-compact health monitoring device, focused on delivering exceptional wearability and high-quality data without compromising sponsor or participant needs. At just 12mm thick and 14mm wide, EmbraceMini is the smallest wristworn actigraphy device for clinical research in the world – the size of a USB flash drive or AA battery. EmbraceMini is an ultra-compact health monitoring device, focused on delivering exceptional wearability and high-quality data without compromising sponsor or participant needs. With its incredibly small footprint and refined looks, EmbraceMini offers effortless, seamless and non-invasive activity data collection while prioritizing the patient
Expensify Expands Global Support for Company Cards, Languages, Billing, and Reimbursements25.6.2025 15:00:00 CEST | Press release
The financial superapp now supports corporate cards from thousands more banks worldwide, alongside a handful of other major international upgrades Expensify, Inc. (Nasdaq: EXFY), the financial management superapp for expenses, travel, and corporate cards, today announced a sweeping expansion of international support across its platform. The launch includes support for corporate card import from 10,000+ more banks worldwide, multilingual capabilities, Euro-based billing, international reimbursements in New Expensify, and beta access to the Expensify Card across the UK, EU, and soon Canada. These updates mark a milestone in Expensify’s global strategy, enabling businesses across the world to manage expenses and cards faster and more seamlessly than ever before—all within a single platform. “Now, companies everywhere can handle expenses, cards, reimbursements, and more — entirely within Expensify,” said David Barrett, founder and CEO of Expensify. Highlights of today’s international expan
Novoloop Raises $21 Million Series B Funding Led by Taranis to Scale Circular Performance Materials25.6.2025 15:00:00 CEST | Press release
Novoloop, a pioneer in advanced chemical recycling, announced today the successful close of its Series B funding round, led by Taranis. The investment will accelerate Novoloop’s commercial scale-up of its proprietary Lifecycling™ technology, which transforms post-consumer polyethylene into high-performance polyol and polyurethane, and support the launch of key customer programs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250624087075/en/ Novoloop successfully closes series B funding round led by Taranis This latest funding round brings Novoloop’s total capital raised to over $50 million and marks a continuation of the company’s significant momentum—demonstrated by achieving continuous operations at its demonstration plant in India, strategic partnerships with world-leading polyurethane producers in China, and progress toward siting its first commercial facility. With continued backing from existing investor Valo Ventures
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom